Articles

Chief Medical Editor's Page

• Applying Clinical Data to Practice in AMD

  By Allen C. Ho, MD Chief Medical Editor and Robert L. Avery, MD Associate Medical Editor

Perspectives: From the Editors of New Retina MD

• The Sunshine Act’s Intimidation Factor

  Will the noble objectives of this law set up a roadblock to innovation?

  By Richard S. Kaiser, MD; and Jonathan L. Prenner, MD

Business of Retina
Pennsylvania Avenue Updates

• Meaningful Use of EHR

  Meaningful use must be demonstrated to earn Medicare incentive payments.

  By Jeremy D. Wolfe, MD

Clinical Trials for the Retina Specialist

• Translating Clinical Trial Results to Practice

  By David Boyer, MD; Matthew Benz, MD; and Alexander Eaton, MD

Fellow's Focus

• Turning Ideas Into Products

  Part 2 of 2 parts. Dealing with companies and taking your idea to market.

  By Nikolas J.S. London, MD; Andre J. Witkin, MD; and Alok S. Bansal, MD with Emmett T. Cunningham Jr., MD, PHD, MPH; Paul E. Tornambe, MD; and Eugene De Juan Jr., MD

Retina Surgery
Retina Pearls

• Single-point Scleral Fixation of a Decentered IOL Without Vitrectomy

  A minimally invasive, straightforward rescue technique.

  By Nicole Siegel, MD; Steven Ness, MD; and Vasiliki Poulaki, MD, PHD

Global Perspectives

• Treatment of Polypoidal Choroidal Vasculopathy

  Individualized plans may be warranted, as the disease course can vary.

  By Won Ki Lee, MD

Surgical Updates

• Extreme Buckling

  By John W. Kitchens, MD

Oncology

• Choroidal Melanoma With Retinal Invasion

  By Timothy V, Johnson, MD; Swathi Kaliki, MD; and Carol L. Shields, MD

Cover Stories

• Intravitreal Aflibercept for AMD: 2-year Results

  The VIEW 1 and 2 studies showed high degrees of safety and efficacy at 2 years.

  By Jeffery S. Heier, MD

• My Use of Aflibercept in Clinical Practice

  By Philip J. Rosenfeld, MD, PHD

• The Consequences of CATT

  How the study results have affected my treatment approach for AMD.

  By Rohit Ross Lakhanpal, MD, FACS

• AMD and Imaging: 2 Articles

  By Glenn J. Jaffe, MD and James D. Palmer, MD

• Radiation Treatments for Neovascular AMD

  By Pravin U. Dugel, MD

• Steroid Implant Alone and as an Adjunct to Anti-VEGF for CNV in AMD

  The extended-release device alone provided clinically and statistically significant improvement in central retinal thickness.

  By Michael A. Singer, MD

• Neuroprotection in Age-related Macular Degeneration

  Preventing apoptosis may not be enough to prevent cell death.

  By Demetrios G. Vavvas, MD, PHD

• Dietary Supplements as Adjuncts in Combination Therapy for AMD

  A new study suggests that nutritional supplements may have the potenial to enhance the effect of anti-VEGF agents plus photodynamic therapy or laser.

  By R. Joseph Olk, MD

Medical Retina

• Combination Therapy for Diffuse DME

  By Keith A. Warren, MD

• Treatment of Retinal Vein Occlusion

  Individualized therapy is crucial to good patient outcomes.

  By Gaurav K. Shah, MD

• 5 Questions With Carl D. Regillo, MD

View All News >